Reaction
Post-Traumatic Headache reporting signals
As of the last recalculation, Post-Traumatic Headache appears in 152 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is RIZATRIPTAN BENZOATE (PRR 207.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rizatriptan Benzoate | 14 | 207.5 | 207.8 |
| Botulinum Toxin Type A | 11 | 130.7 | 130.8 |
| Memantine | 12 | 130.3 | 130.4 |
| Memantine Hydrochloride | 12 | 130.3 | 130.4 |
| Erenumab-Aooe | 16 | 44.3 | 44.3 |